A Phase I Trial Combining Triapine With Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
This early-stage study tests a new combination treatment for brain tumors like glioblastoma and astrocytoma that have returned after previous care. Researchers want to find the safest and most effective dose of an experimental drug called Triapine when used alongside radiation therapy.
Adults with confirmed brain tumors (such as recurrent astrocytomas or glioblastomas grades 2 through 4) whose tumors are a specific size may be eligible. Participants must also have recovered from past treatment side effects and meet certain medical health criteria.
Participants will receive the experimental drug Triapine combined with specialized radiation therapy to target the cancer. Throughout the process, doctors will monitor your health closely using imaging scans and small tissue or fluid tests.
This study is currently recruiting patients and takes place at multiple locations in California, United States including Duarte, Irvine, and La Jolla.
- 1Combines an experimental drug called Triapine with radiation therapy
- 2Aims to safely treat brain tumors that have returned after previous treatments
- 3Currently recruiting patients at several medical centers in California
No related links yet
Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.
Suggest a linkThis summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.